Skip to content

Zadroga ActWTC Health ProgramVictim Compensation Fund

Barasch & McGarry Recognizes Gallbladder and Bile Duct Cancer Awareness Month

February 9, 2021 | Michael Barasch

Exposure to Ground Zero toxins after 9/11 has contributed to a dramatically higher risk of 68 different types of cancer, including relatively rare gallbladder and bile duct cancers.

Barasch & McGarry represents many 9/11 first responders and survivors who have been diagnosed with gallbladder and bile duct cancer.

A recent report from the American Cancer Society estimates that about 12,000 Americans were diagnosed with gallbladder cancer in 2020, with another 8,000 people developing bile duct cancer.

Women account for two-thirds of gallbladder and bile duct cancer diagnoses, as well as two-thirds of deaths.

But early detection of the disease can substantially improve likelihood of survival.

Key risk factors for gallbladder and bile duct cancer include gallstones, smoking, family history, old age, and obesity – in addition to toxic exposure from Ground Zero after 9/11.

If you are at risk for gallbladder and bile duct cancer as a member of the 9/11 community, be sure to speak with your primary care provider about accessing diagnostic exams such as a liver function test and imaging tests to determine if there are any problems.

Also stay alert to symptoms such as abdominal pain, nausea or vomiting, jaundice (yellowing of the skin and eyes), and lumps in the belly.

If you are diagnosed with gallbladder or bile duct cancer or any of the other cancers or respiratory diseases impacting the 9/11 community, we can help you access resources through the World Trade Center Health Program and the 9/11 Victim Compensation Fund. 

Visit or call 212-385-8000 today.

Leave a Reply

Your email address will not be published. All fields are required

Leave a comment

  • Share this article

  • Newsletter

    Stay updated on breaking 9/11 news
    Subscribe Now

Home Live Chat

Photo of Michael Barasch.
Online Now

Hi, we are here to help if you have questions.